73 related articles for article (PubMed ID: 7511016)
1. Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma.
Damron EP; Qazilbash MH; Fang PQ; Wu SY; Dabaja BS; Rondon G; Hosing C; Champlin RE; Bashir Q; Shpall EJ; Knafl MK; Lee HC; Manasanch EE; Patel K; Thomas SK; Orlowski RZ; Weber DM; Pinnix CC; Gunther JR
Transplant Cell Ther; 2023 Jan; 29(1):37.e1-37.e7. PubMed ID: 37753818
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the Utility of Granulocyte Colony-Stimulating Factor Post-Autologous Hematopoietic Stem Cell Transplantation for Outpatient-Based Transplantations.
Portuguese AJ; Holmberg L; Hill GR; Lee SJ; Green DJ; Mielcarek M; Gooley T; Yeh AC
Transplant Cell Ther; 2023 Nov; 29(11):696.e1-696.e7. PubMed ID: 37634844
[TBL] [Abstract][Full Text] [Related]
3. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.
Zekri AR; Salama H; Medhat E; Musa S; Abdel-Haleem H; Ahmed OS; Khedr HA; Lotfy MM; Zachariah KS; Bahnassy AA
Stem Cell Res Ther; 2015 Jun; 6(1):118. PubMed ID: 26062731
[TBL] [Abstract][Full Text] [Related]
4. Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities.
Toren A; Nagler R; Nagler A
Med Oncol; 1998 Jul; 15(2):113-8. PubMed ID: 9789219
[TBL] [Abstract][Full Text] [Related]
5. Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study.
Mamo T; Sumstad D; DeFor TE; Cao Q; MacMillan ML; Brunstein C; Juckett M; McKenna DH
Transplant Cell Ther; 2023 Oct; 29(10):638.e1-638.e8. PubMed ID: 37419326
[TBL] [Abstract][Full Text] [Related]
6. Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol.
Johnson AK; Lorimer EL; Szabo A; Wu R; Shah NN; D'Souza A; Chhabra S; Hamadani M; Dhakal B; Hari P; Rao S; Carlson K; Williams CL; Knight JM
Yale J Biol Med; 2022 Mar; 95(1):45-56. PubMed ID: 35370486
[TBL] [Abstract][Full Text] [Related]
7. Mobilization of hematopoietic progenitor cells with granulocyte colony stimulating factors for autologous transplant in hematologic malignancies: a single center experience.
Gabús R; Borelli G; Ferrando M; Bódega E; Citrín E; Jiménez CO; Alvarez R
Rev Bras Hematol Hemoter; 2011; 33(6):410-6. PubMed ID: 23049356
[TBL] [Abstract][Full Text] [Related]
8. A comparative review of colony-stimulating factors.
Nemunaitis J
Drugs; 1997 Nov; 54(5):709-29. PubMed ID: 9360058
[TBL] [Abstract][Full Text] [Related]
9. Clinical role of GM-CSF in neutrophil recovery in relation to health care parameters.
Hofstra LS; de Vries EG; Uyl-de Groot CA; Vellenga E
Med Oncol; 1996 Sep; 13(3):177-84. PubMed ID: 9106177
[TBL] [Abstract][Full Text] [Related]
10. Improvement of hematologic recovery after high-dose intensification using peripheral blood progenitor cells (PBPC) mobilized by chemotherapy and GM-CSF.
Lamy T; Drenou B; Grulois I; Leberre C; Dauriac C; Amiot L; Godard M; Fauchet R; LePrise PY
Ann Hematol; 1994 Dec; 69(6):297-302. PubMed ID: 7993937
[TBL] [Abstract][Full Text] [Related]
11. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.
Frampton JE; Lee CR; Faulds D
Drugs; 1994 Nov; 48(5):731-60. PubMed ID: 7530630
[TBL] [Abstract][Full Text] [Related]
12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
[TBL] [Abstract][Full Text] [Related]
14. Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy.
Zimmerman TM; Mick R; Myers S; Bender JG; Lee WJ; Williams SF
Bone Marrow Transplant; 1995 Jun; 15(6):923-7. PubMed ID: 7581092
[TBL] [Abstract][Full Text] [Related]
15. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
16. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
17. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.
Bolwell BJ; Goormastic M; Yanssens T; Dannley R; Baucco P; Fishleder A
Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]